deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT04153513

Effect of Lanolin and Breastmilk in the Treatment of Sore and Damaged Nipples in Breastfeeding Women

Comparison of the Effect of Lanolin and Breastmilk in the Treatment of Sore and Damaged Nipples in Breastfeeding Women- a Randomized Controlled Trial

Sponsor: Clinical Hospital Centre Zagreb

Conditions Breastfeeding
Updated 6 times since 2019 Last updated: Feb 11, 2021 Started: Jan 1, 2019 Primary completion: Sep 30, 2020 Completion: Sep 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Breastfeeding, this trial is completed. The trial is conducted by Clinical Hospital Centre Zagreb and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2019 – ~Oct 2020 · 10 months · monthly snapshotRecruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotCompleted~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Mar 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Mar 2021 [monthly]

    Completed PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

Show 1 earlier version
  1. Dec 2019 — Oct 2020 [monthly]

    Recruiting PHASE2

    First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinical Hospital Centre Zagreb
  • University of Mostar
Data source: University of Mostar

For direct contact, visit the study record on ClinicalTrials.gov .